Doctor-prescribed treatment
PreclinicalSmall molecule
Doctor-prescribed treatment is one of 3 small molecule programs targeting Hand-foot syndrome. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
2 competitors in Hand-Foot Syndrome
#DrugCompanyPhaseTrials
1Celebrex
PPhiladelphia Eye Associates
Approved
Sterile Urea
PfizerPreclinical
Doctor-prescribed treatment
AAffiliated Hospital of Qinghai University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Hand-foot syndrome1 trial
Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome
Recruiting·—·N/A·NCT06602167·220 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Doctor-prescribed treatment. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details